Women's Health Considerations for Lipid Management

Endocrinology and Metabolism Clinics of North America
Robert WildEdward A Gill

Abstract

Understanding opportunities to reduce dyslipidemia before, during, and after pregnancy has major implications for cardiovascular disease risk prevention for the entire population. The best time to screen for dyslipidemia is before pregnancy or in the early antenatal period. The differential diagnosis of hypertriglyceridemia in pregnancy is the same as in nonpregnant women except that clinical lipidologists need to be aware of the potential obstetric complications associated with hypertriglyceridemia. Dyslipidemia discovered during pregnancy should be treated with diet and exercise intervention, as well as glycemic control if indicated. A complete lipid profile assessment during each trimester of pregnancy is recommended.

References

Dec 1, 1979·Australian and New Zealand Journal of Medicine·J M Potter, W B Macdonald
Sep 14, 1995·The New England Journal of Medicine·J E MansonF E Speizer
Feb 21, 2007·Circulation·Marianne CanonicoUNKNOWN Estrogen and Thromboembolism Risk (ESTHER) Study Group
Aug 12, 2008·American Journal of Obstetrics and Gynecology·Graeme N SmithUNKNOWN Pre-Eclampsia New Emerging Team (PE-NET)
Jun 9, 2009·Obstetrics and Gynecology Clinics of North America·Erica P Gunderson
Jul 28, 2009·American Journal of Obstetrics and Gynecology·Arnon WiznitzerLena Novack
Oct 5, 2010·Journal of the American College of Cardiology·David TanousCandice K Silversides
Jul 15, 2011·American Journal of Obstetrics and Gynecology·Lucinda E KjerulffDaniel Duffy
Mar 1, 2012·Menopause : the Journal of the North American Menopause Society·UNKNOWN North American Menopause Society
May 29, 2012·The Journal of Clinical Endocrinology and Metabolism·Alyse S Goldberg, Robert A Hegele
Aug 31, 2012·The Journal of Clinical Endocrinology and Metabolism·Tanja G M VrijkotteMarcel B Twickler
Sep 20, 2012·Menopause : the Journal of the North American Menopause Society·Samar R El KhoudaryKim Sutton-Tyrrell
Oct 24, 2013·The Journal of Clinical Endocrinology and Metabolism·Richard S LegroUNKNOWN Endocrine Society
Nov 26, 2013·Heart, Lung & Circulation·Francesca CharltonAnnemarie Hennessy
Mar 1, 2014·Iranian Red Crescent Medical Journal·Mitra ZarratiElham Razmpoosh
May 23, 2014·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Karen SangaKirsten I Black
May 27, 2014·The American Journal of Medicine·Tracy L Setji, Ann J Brown
Jun 24, 2014·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·Z Asemi, A Esmaillzadeh

❮ Previous
Next ❯

Citations

Nov 14, 2020·Journal of Reproductive Immunology·Amin AbbasiLeili Aghebati-Maleki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.